• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Gastrointestinal

  • A cross-sectional, Canadian, multi-centre study of symptom burden and clinical management in subjects with Gastroesophageal Reflux Disease (GERD) RANGE: Retrospective ANalysis of GErd

Disease
gastrointestinal diseases
Drug Name
Nexium
Generic Name
esomeprazole
Sponsor
AstraZeneca
Drug Status
Approved Medicine
Phase
Non-Interventional Study
Start Date
Jan 14, 2008
Study Name
D9612L00113
Study Id
D9612L00113
ClinicalTrials.gov ID
NCT00634023
Recruiting Status
Closed
Protocol Status
Not Available
Report
Jan 18, 1971
  • D9612L00113.pdf (19 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013